Prevacid Iv patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).


Feb, 2022

(1 year, 7 months ago)

Prevacid Iv is owned by Takeda Pharms Na.

Prevacid Iv contains Lansoprazole.

Prevacid Iv has a total of 1 drug patent out of which 1 drug patent has expired.

Expired drug patents of Prevacid Iv are:

  • US7396841*PED

Prevacid Iv was authorised for market use on 27 May, 2004.

Prevacid Iv is available in injectable;intravenous dosage forms.

The generics of Prevacid Iv are possible to be released after 17 February, 2022.

Drugs and Companies using LANSOPRAZOLE ingredient

Market Authorisation Date: 27 May, 2004

Treatment: NA


More Information on Dosage

PREVACID IV family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic